ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
3,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
4,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
4,2,Psychotic behaviour,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
5,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
6,1,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
7,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
7,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
7,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
9,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
9,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
10,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
11,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
12,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
13,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
13,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
14,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
14,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
15,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
16,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
17,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
18,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
18,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
19,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
20,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
20,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
21,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
21,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
21,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
21,4,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
21,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
21,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
22,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
23,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
24,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
24,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
24,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
24,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
24,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
24,6,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
25,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
25,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
25,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
25,4,Pharyngeal erythema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
25,5,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
25,6,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
26,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
27,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
27,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
27,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
27,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
27,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
28,1,Mesothelioma,Mesotheliomas malignant and unspecified,Mesotheliomas,Neopl,Y
29,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
29,2,Hypotonia neonatal,Muscle tone abnormalities,Muscle disorders,Musc,N
29,3,Hypoventilation neonatal,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
30,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
30,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
31,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
31,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
32,1,Myopia,Refractive and accommodative disorders,Vision disorders,Eye,N
33,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
33,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
34,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
35,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
35,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
36,1,Retrograde ejaculation,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
37,1,Injection site ulcer,Injection site reactions,Administration site reactions,Genrl,N
37,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
38,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
38,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
39,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
40,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
41,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
42,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
43,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
44,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
44,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
45,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
46,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
46,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
47,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
48,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
48,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
48,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
48,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
49,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
49,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
49,3,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
49,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
50,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
50,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
50,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
50,4,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
51,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
52,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
52,2,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
52,3,Circadian rhythm sleep disorder,Disturbances in sleep phase rhythm,Sleep disturbances (incl subtypes),Nerv,N
52,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
52,5,Consciousness fluctuating,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
52,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
52,7,Delirium,Deliria,Deliria (incl confusion),Psych,N
52,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
52,9,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,10,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
52,11,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
52,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
52,13,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
52,14,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
52,15,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
52,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
52,17,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
52,18,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
52,19,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
52,20,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
53,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
53,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
53,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
53,4,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
54,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
54,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
55,1,Angular cheilitis,Oral soft tissue infections,Oral soft tissue conditions,Gastr,N
55,2,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
55,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
55,4,Tongue erythema,Tongue signs and symptoms,Tongue conditions,Gastr,N
56,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
56,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
56,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
56,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
56,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
56,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
56,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
57,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
57,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
57,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
57,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
57,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
58,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
58,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
59,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
59,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
59,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
60,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
61,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
62,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
62,2,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
63,1,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
63,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
63,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
64,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
64,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
65,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
66,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
67,1,Akathisia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
68,1,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
69,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
69,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
69,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
69,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
69,5,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
69,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
69,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
69,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
69,9,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
70,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
71,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
71,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
71,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
71,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
71,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
71,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
71,7,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
71,8,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
71,9,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
71,10,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
72,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
72,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
72,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
72,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
73,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
73,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
73,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
73,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
73,5,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
73,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
73,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
73,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
73,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
73,10,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
73,11,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
74,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
75,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
75,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
76,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
76,2,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
76,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
76,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
77,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
77,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
78,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
79,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
79,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
79,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
80,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
80,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
80,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
80,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
80,5,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
80,6,Neuroleptic malignant syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
80,7,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
80,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
81,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
81,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
82,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
82,2,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
83,1,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
83,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
83,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
84,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
84,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
84,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
84,4,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
85,1,Delusion of grandeur,Delusional symptoms,Disturbances in thinking and perception,Psych,N
85,2,Mental disability,Disability issues,Lifestyle issues,SocCi,N
85,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
85,4,Persecutory delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
85,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
85,6,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
86,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
87,1,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
88,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
88,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
88,3,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
88,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
88,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
88,6,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
89,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
89,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
89,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
89,4,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
89,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
89,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
90,1,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
91,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
91,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
92,1,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
93,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
93,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
94,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
95,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
96,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
97,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
97,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
98,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
98,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
100,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
100,2,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
101,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
101,2,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
101,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
102,2,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
103,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
103,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
103,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
104,1,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
105,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
106,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
106,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
107,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
